The systemic response to CNS injury

Experimental Neurology

Volumn 258, Issue , 2014, Pages 105-111

  Anthony, Daniel C ^a   Couch, Yvonne ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE;

CENTRAL NERVOUS SYSTEM INJURY; CONCURRENT INFECTION; ENCEPHALITIS; GENE EXPRESSION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LIVER; LUNG; MYELITIS; NERVE CELL LESION; NERVOUS SYSTEM INJURY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; ORGAN INJURY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SPLEEN;

ANIMALS; BRAIN INJURIES; CELL MOVEMENT; CHEMOKINES; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; SPINAL CORD INJURIES;

EID: 84904736884     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.03.013     Document Type: Review

References (84)

1. Ali S., Mann D.A. Signal transduction via the NF-kappaB pathway: a targeted treatment modality for infection, inflammation and repair. Cell Biochem. Funct. 2004, 22:67-79.
2. Andersson P.B., Perry V.H., Gordon S. The CNS acute inflammatory response to excitotoxic neuronal cell death. Immunol. Lett. 1991, 30:177-182.
3. Andersson P.B., Perry V.H., Gordon S. The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 1991, 42:201-214.
4. Andersson P.B., Perry V.H., Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 1992, 48:169-186.
5. Anthony D.C., Couch Y., Losey P., Evans M.C. The systemic response to brain injury and disease. Brain Behav. Immun. 2012, 26:534-540.
6. Bao F., Bailey C.S., Gurr K.R., Bailey S.I., Rosas-Arellano M.P., Dekaban G.A., Weaver L.C. Increased oxidative activity in human blood neutrophils and monocytes after spinal cord injury. Exp. Neurol. 2009, 215:308-316.
7. Bao F., Bailey C.S., Gurr K.R., Bailey S.I., Rosas-Arellano M.P., Brown A., Dekaban G.A., Weaver L.C. Human spinal cord injury causes specific increases in surface expression of beta integrins on leukocytes. J. Neurotrauma 2011, 28:269-280.
8. Baumann H., Gauldie J. The acute-phase response. Immunol. Today 1994, 15:74-80.
9. Bell M.D., Perry V.H. Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degeneration. J. Neurocytol. 1995, 24:695-710.
10. Bernardes-Silva M., Anthony D.C., Issekutz A.C., Perry V.H. Recruitment of neutrophils across the blood-brain barrier: the role of E- and P-selectins. J. Cereb. Blood Flow Metab. 2001, 21:1115-1124.
11. Blond D., Campbell S.J., Butchart A.G., Perry V.H., Anthony D.C. Differential induction of interleukin-1beta and tumour necrosis factor-alpha may account for specific patterns of leukocyte recruitment in the brain. Brain Res. 2002, 958:89-99.
12. Bolton S.J., Perry V.H. Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats. Exp. Neurol. 1998, 154:231-240.
13. Bordet R., Deplanque D., Maboudou P., Puisieux F., Pu Q., Robin E., Martin A., Bastide M., Leys D., Lhermitte M., Dupuis B. Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J. Cereb. Blood Flow Metab. 2000, 20:1190-1196.
14. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
15. Breder C.D., Hazuka C., Ghayur T., Klug C., Huginin M., Yasuda K., Teng M., Saper C.B. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:11393-11397.
16. Buljevac D., Flach H.Z., Hop W.C., Hijdra D., Laman J.D., Savelkoul H.F., van Der Meche F.G., van Doorn P.A., Hintzen R.Q. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002, 125:952-960.
17. Campbell S.J., Wilcockson D.C., Butchart A.G., Perry V.H., Anthony D.C. Altered chemokine expression in the spinal cord and brain contributes to differential interleukin-1beta-induced neutrophil recruitment. J. Neurochem. 2002, 83:432-441.
18. Campbell S.J., Hughes P.M., Iredale J.P., Wilcockson D.C., Waters S., Docagne F., Perry V.H., Anthony D.C. CINC-1 is identified as an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J. 2003, 17:1168-1170.
19. Campbell S., Perry V., Pitossi F., Butchart A., Chertoff M., Waters S., Dempster R., Anthony D. Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am. J. Pathol. 2005, 166:1487-1497.
20. Campbell S., Jiang Y., Davis A., Farrands R., Holbrook J., Leppert D., Anthony D. Immunomodulatory effects of etanercept in a model of brain injury act through attenuation of the acute-phase response. J. Neurochem. 2007, 103:2245-2255.
21. Campbell S.J., Anthony D.C., Oakley F., Carlsen H., Elsharkawy A.M., Blomhoff R., Mann D.A. Hepatic nuclear factor kappa B regulates neutrophil recruitment to the injured brain. J. Neuropathol. Exp. Neurol. 2008, 67:223-230.
22. Campbell S.J., Zahid I., Losey P., Law S., Jiang Y.Y., Bilgen M., van Rooijen N., Morsali D., Davis A.E.M., Anthony D.C. Liver Kupffer cells control the magnitude of the inflammatory response in the injured brain and spinal cord. Neuropharmacology 2008, 55:780-787.
23. Campbell S.J., Meier U., Mardiguian S., Jiang Y., Littleton E.T., Bristow A., Relton J., Connor T.J., Anthony D.C. Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE. Brain Behav. Immun. 2010, 24:738-746.
24. Chamorro A., Urra X., Planas A.M. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 2007, 38:1097-1103.
25. Chollet F., Tardy J., Albucher J.F., Thalamas C., Berard E., Lamy C., Bejot Y., Deltour S., Jaillard A., Niclot P., Guillon B., Moulin T., Marque P., Pariente J., Arnaud C., Loubinoux I. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011, 10:123-130.
26. Combrinck M.I., Perry V.H., Cunningham C. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 2002, 112:7-11.
27. Couch Y., Anthony D.C., Dolgov O., Revischin A., Festoff B., Santos A.I., Steinbusch H.W., Strekalova T. Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain Behav. Immun. 2013, 29:136-146.
28. Couch Y., Martin C.J., Howarth C., Raley J., Khrapitchev A.A., Stratford M., Sharp T., Sibson N.R., Anthony D.C. Systemic inflammation alters central 5-HT function as determined by pharmacological MRI. Neuroimage 2013, 75C:185-194.
29. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. N. Y. Acad. Sci. 2001, 933:222-234.
30. Davis A., Campbell S., Wilainam P., Anthony D. Post-conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: a potential neuroprotective treatment. Eur. J. Neurosci. 2005, 22:2441-2450.
31. De La Garza R. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci. Biobehav. Rev. 2005, 29:761-770.
32. de Vries D.K., Lindeman J.H., Ringers J., Reinders M.E., Rabelink T.J., Schaapherder A.F. Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantation. Am J Transplant 2011, 11:1064-1070.
33. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
34. Fan L., Young P.R., Barone F.C., Feuerstein G.Z., Smith D.H., McIntosh T.K. Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res. Mol. Brain Res. 1995, 30:125-130.
35. Feuerstein G.Z., Liu T., Barone F.C. Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc. Brain Metab. Rev. 1994, 6:341-360.
36. Fleming J.C., Bailey C.S., Hundt H., Gurr K.R., Bailey S.I., Cepinskas G., Lawendy A.R., Badhwar A. Remote inflammatory response in liver is dependent on the segmental level of spinal cord injury. J. Trauma. acute care surg. 2012, 72:1194-1201. (discussion 1202).
37. Galea J., Brough D. The role of inflammation and interleukin-1 in acute cerebrovascular disease. J. Inflamm. Res 2013, 6:121-128.
38. Ge S., Pachter J.S. Isolation and culture of microvascular endothelial cells from murine spinal cord. J. Neuroimmunol. 2006, 177:209-214.
39. Grau A.J., Buggle F., Heindl S., Steichen-Wiehn C., Banerjee T., Maiwald M., Rohlfs M., Suhr H., Fiehn W., Becher H., et al. Recent infection as a risk factor for cerebrovascular ischemia. Stroke 1995, 26:373-379.
40. Grau A.J., Buggle F., Steichen-Wiehn C., Heindl S., Banerjee T., Seitz R., Winter R., Forsting M., Werle E., Bode C., et al. Clinical and biochemical analysis in infection-associated stroke. Stroke 1995, 26:1520-1526.
41. Guth L., Zhang Z., DiProspero N.A., Joubin K., Fitch M.T. Spinal cord injury in the rat: treatment with bacterial lipopolysaccharide and indomethacin enhances cellular repair and locomotor function. Exp. Neurol. 1994, 126:76-87.
42. Guth L., Zhang Z., Roberts E. Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:12308-12312.
43. Gwak Y.S., Kang J., Unabia G.C., Hulsebosch C.E. Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats. Exp. Neurol. 2012, 234:362-372.
44. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
45. Higgins G.A., Olschowka J.A. Induction of interleukin-1 beta mRNA in adult rat brain. Brain Res. Mol. Brain Res. 1991, 9:143-148.
46. Holub M., Cheng C.W., Mott S., Wintermeyer P., van Rooijen N., Gregory S.H. Neutrophils sequestered in the liver suppress the proinflammatory response of Kupffer cells to systemic bacterial infection. J. Immunol. 2009, 183:3309-3316.
47. Hundt H., Fleming J.C., Phillips J.T., Lawendy A., Gurr K.R., Bailey S.I., Sanders D., Bihari R., Gray D., Parry N., Bailey C.S., Badhwar A. Assessment of hepatic inflammation after spinal cord injury using intravital microscopy. Injury 2011, 42:691-696.
48. Jensen L.E., Whitehead A.S. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 1998, 334(Pt 3):489-503.
49. Jiang Y., Deacon R., Anthony D., Campbell S. Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases. Neurobiol. Dis. 2008, 32:125-132.
50. Kapinya K.J., Lowl D., Futterer C., Maurer M., Waschke K.F., Isaev N.K., Dirnagl U. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 2002, 33:1889-1898.
51. Koj A. Initiation of acute phase response and synthesis of cytokines. Biochim. Biophys. Acta 1996, 1317:84-94.
52. Koj A. Termination of acute-phase response: role of some cytokines and anti-inflammatory drugs. Gen. Pharmacol. 1998, 31:9-18.
53. Konsman J.P., Luheshi G.N., Bluthe R.M., Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur. J. Neurosci. 2000, 12:4434-4446.
54. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002, 25:154-159.
55. Kushner I. Regulation of the acute phase response by cytokines. Perspect. Biol. Med. 1993, 36:611-622.
56. Lawson L.J., Perry V.H., Dri P., Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990, 39:151-170.
57. Lawson L.J., Frost L., Risbridger J., Fearn S., Perry V.H. quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic-nerve. J. Neurocytol 1994, 23:729-744.
58. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., Feuerstein G.Z., Kukreja R.C. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994, 25:1481-1488.
59. Luheshi G.N., Bluthe R.M., Rushforth D., Mulcahy N., Konsman J.P., Goldbach M., Dantzer R. Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton Neurosci 2000, 85:127-132.
60. Marty S., Dusart I., Peschanski M. Glial changes following an excitotoxic lesion in the CNS. I. Microglia/macrophages. Neuroscience 1991, 45:529-539.
61. McColl B.W., Rothwell N.J., Allan S.M. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J. Neurosci. 2007, 27:4403-4412.
62. McCormick Z., Lynch M., Chen D. Fever after traumatic spinal cord injury: a case of Brucella sepsis. PM R 2013, 5:982-984.
63. Olson J.K. Immune response by microglia in the spinal cord. Ann. N. Y. Acad. Sci. 2010, 1198:271-278.
64. Perry V.H., Bell M.D., Brown H.C., Matyszak M.K. Inflammation in the nervous system. Curr. Opin. Neurobiol. 1995, 5:636-641.
65. Popovich P.G., Tovar C.A., Wei P., Fisher L., Jakeman L.B., Basso D.M. A reassessment of a classic neuroprotective combination therapy for spinal cord injured rats: LPS/pregnenolone/indomethacin. Exp. Neurol. 2012, 233:677-685.
66. Quan N., Sundar S.K., Weiss J.M. Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J. Neuroimmunol. 1994, 49:125-134.
67. Rosenzweig H.L., Lessov N.S., Henshall D.C., Minami M., Simon R.P., Stenzel-Poore M.P. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 2004, 35:2576-2581.
68. Sauter C., Wolfensberger C. Interferon in human serum after injection of endotoxin. Lancet 1980, 2:852-853.
69. Schnell L., Fearn S., Klassen H., Schwab M.E., Perry V.H. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur. J. Neurosci. 1999, 11:3648-3658.
70. Schnell L., Fearn S., Schwab M.E., Perry V.H., Anthony D.C. Cytokine-induced acute inflammation in the brain and spinal cord. J. Neuropathol. Exp. Neurol. 1999, 58:245-254.
71. Schomberg D., Olson J.K. Immune responses of microglia in the spinal cord: contribution to pain states. Exp. Neurol. 2012, 234:262-270.
72. Sibson N.R., Blamire A.M., Perry V.H., Gauldie J., Styles P., Anthony D.C. TNF-alpha reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway. Brain 2002, 125:2446-2459.
73. Simon R.P., Niiro M., Gwinn R. Prior ischemic stress protects against experimental stroke. Neurosci. Lett. 1993, 163:135-137.
74. Sinyor D., Amato P., Kaloupek D.G., Becker R., Goldenberg M., Coopersmith H. Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcome. Stroke 1986, 17:1102-1107.
75. Sobel R.A., Mitchell M.E., Fondren G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 1990, 136:1309-1316.
76. Syrjanen J., Valtonen V.V., Iivanainen M., Kaste M., Huttunen J.K. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br. Med. J. (Clin. Res. Ed.) 1988, 296:1156-1160.
77. Szalai A.J., van Ginkel F.W., Wang Y., McGhee J.R., Volanakis J.E. Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component. J. Immunol. 2000, 165:1030-1035.
78. Towfighi J., Housman C., Mauger D., Vannucci R.C. Effect of seizures on cerebral hypoxic-ischemic lesions in immature rats. Brain Res. Dev. Brain Res. 1999, 113:83-95.
79. Vela J.M., Dalmau I., Acarin L., Gonzalez B., Castellano B. Microglial cell reaction in the gray and white matter in spinal cords from jimpy mice. An enzyme histochemical study at the light and electron microscope level. Brain Res. 1995, 694:287-298.
80. Williams K.C., Hickey W.F. Traffic of hematogenous cells through the central nervous system. Curr. Top. Microbiol. Immunol. 1995, 202:221-245.
81. Windle W.F., Chambers W.W. Regeneration in the spinal cord of the cat and dog. J. Comp. Neurol. 1950, 93:241-257.
82. Woodroofe M.N., Sarna G.S., Wadhwa M., Hayes G.M., Loughlin A.J., Tinker A., Cuzner M.L. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 1991, 33:227-236.
83. Yabuuchi K., Minami M., Katsumata S., Yamazaki A., Satoh M. An in situ hybridization study on interleukin-1 beta mRNA induced by transient forebrain ischemia in the rat brain. Brain Res. Mol. Brain Res. 1994, 26:135-142.
84. Yang S.K., Wang Y.C., Chao C.C., Chuang Y.J., Lan C.Y., Chen B.S. Dynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNFalpha-induced inflammatory responses. BMC Med. Genet. 2010, 3:19.